+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Pruritus Drugs Market 2019-2023 - Product Image

Global Pruritus Drugs Market 2019-2023

  • ID: 4804073
  • Report
  • July 2019
  • Region: Global
  • 143 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Allergan Plc
  • Astellas Pharma Inc.
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Sanofi.
  • MORE
Global Pruritus Drugs Market: About this market

Pruritus drugs are used to treat itches associated with skin or systemic diseases. The pruritus drugs market analysis considers sales from the topical, oral, and parenteral segments. The market is also segmented based on application into hematologic pruritus, oncological pruritus, renal pruritus, endocrine pruritus, and cholestatic pruritus. This analysis also considers the sales of pruritus drugs in Asia, Europe, North America, and ROW. In 2018, the hematologic pruritus segment held the highest market share. However, the oncological pruritus segment will lead in terms of market share over the forecast period owing to rising oncological indications that cause pruritus. Almost all types of cancers put patients at increased risk of developing pruritus. Also, our global pruritus drugs report has observed market growth factors such as the growing preference for immunotherapy and rising prevalence of chronic diseases. However, the availability of alternative therapies, complex pathogenesis, and poor patient adherence may hamper the growth of the pruritus drugs industry over the forecast period.

Global Pruritus Drugs Market: Overview

Growing preference for immunotherapy

The rising use of immunotherapy drugs to treat oncological indications is increasing the incidence of pruritus. As a result, the demand for pruritus drugs such as topical emollients, antihistamines, and topical corticosteroids is increasing. The high efficacy of immunotherapy in treat cancer is not allowing patients to withdraw from the treat. Therefore, the growing preference for immunotherapy will help market vendors in increasing sales. This will contribute to the growth of the global pruritus drugs market at over 5% CAGR during the forecast period.

Nanoparticle-enabled transdermal drug delivery systems

Transdermal drug delivery is not effective in the delivery of small and lipophilic drugs. As a result, vendors have come up with nanoparticle-enabled transdermal drug delivery systems, which provide faster onset of action. They are also less painful compared with routes that require incisions. Moreover, biodegradable nanoparticles can prolong the duration of drug adhesion. These factors will increase the adoption of nanoparticle-enabled transdermal drug delivery systems, which will have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global pruritus drugs market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global pruritus drugs market is fragmented. This robust vendor analysis is designed to help clients in improving their market positions, and in line with this, this report provides a detailed analysis of several leading Pruritus Drugs manufacturers, which include Allergan Plc, Astellas Pharma Inc., GlaxoSmithKline Plc, Pfizer Inc., and Sanofi.

Also, the pruritus drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan Plc
  • Astellas Pharma Inc.
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Sanofi.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY APPLICATION
  • Market segmentation by application
  • Comparison by application
  • Hematologic pruritus - Market size and forecast 2018-2023
  • Oncological pruritus - Market size and forecast 2018-2023
  • Renal pruritus - Market size and forecast 2018-2023
  • Endocrine pruritus - Market size and forecast 2018-2023
  • Cholestatic pruritus - Market size and forecast 2018-2023
  • Market opportunity by application
PART 08: MARKET SEGMENTATION BY ROA

PART 09: CUSTOMER LANDSCAPE

PART 10: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 15: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Allergan Plc
  • Astellas Pharma Inc.
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Sanofi
PART 16: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
PART 17: About the Author


List of Exhibits
Exhibit 01: Product overview
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Global pruritus drugs market pipeline: Overview
Exhibit 19: Global pruritus drugs market pipeline: Snapshot
Exhibit 20: Application - Market share 2018-2023 (%)
Exhibit 21: Comparison by application
Exhibit 22: Hematologic pruritus - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Hematologic pruritus - Year-over-year growth 2019-2023 (%)
Exhibit 24: Oncological pruritus - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Oncological pruritus - Year-over-year growth 2019-2023 (%)
Exhibit 26: Renal pruritus - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Renal pruritus - Year-over-year growth 2019-2023 (%)
Exhibit 28: Endocrine pruritus - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: Endocrine pruritus - Year-over-year growth 2019-2023 (%)
Exhibit 30: Cholestatic pruritus - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Cholestatic pruritus - Year-over-year growth 2019-2023 (%)
Exhibit 32: Market opportunity by application
Exhibit 33: RoA - Market share
Exhibit 34: Few prominent topical drugs
Exhibit 35: Customer landscape
Exhibit 36: Market share by geography 2018-2023 (%)
Exhibit 37: Geographic comparison
Exhibit 38: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: North America - Year-over-year growth 2019-2023 (%)
Exhibit 40: Top 3 countries in North America
Exhibit 41: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 42: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 43: Top 3 countries in Europe
Exhibit 44: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 45: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 46: Top 3 countries in Asia
Exhibit 47: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 48: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 49: Top 3 countries in ROW
Exhibit 50: Key leading countries
Exhibit 51: Market opportunity
Exhibit 52: Indications that are associated with pruritus
Exhibit 53: Impact of drivers and challenges
Exhibit 54: Vendor landscape
Exhibit 55: Landscape disruption
Exhibit 56: Vendors covered
Exhibit 57: Vendor classification
Exhibit 58: Market positioning of vendors
Exhibit 59: Allergan Plc - Vendor overview
Exhibit 60: Allergan Plc - Business segments
Exhibit 61: Allergan Plc - Organizational developments
Exhibit 62: Allergan Plc - Geographic focus
Exhibit 63: Allergan Plc - Segment focus
Exhibit 64: Allergan Plc - Key offerings
Exhibit 65: Allergan Plc - Key customers
Exhibit 66: Astellas Pharma Inc. - Vendor overview
Exhibit 67: Astellas Pharma Inc. - Business segments
Exhibit 68: Astellas Pharma Inc. - Organizational developments
Exhibit 69: Astellas Pharma Inc. - Geographic focus
Exhibit 70: Astellas Pharma Inc. - Key offerings
Exhibit 71: Astellas Pharma Inc. - Key customers
Exhibit 72: GlaxoSmithKline Plc - Vendor overview
Exhibit 73: GlaxoSmithKline Plc - Business segments
Exhibit 74: GlaxoSmithKline Plc - Organizational developments
Exhibit 75: GlaxoSmithKline Plc - Geographic focus
Exhibit 76: GlaxoSmithKline Plc - Segment focus
Exhibit 77: GlaxoSmithKline Plc - Key offerings
Exhibit 78: GlaxoSmithKline Plc - Key customers
Exhibit 79: Pfizer Inc. - Vendor overview
Exhibit 80: Pfizer Inc. - Business segments
Exhibit 81: Pfizer Inc. - Organizational developments
Exhibit 82: Pfizer Inc. - Geographic focus
Exhibit 83: Pfizer Inc. - Segment focus
Exhibit 84: Pfizer Inc. - Key offerings
Exhibit 85: Pfizer Inc. - Key customers
Exhibit 86: Sanofi - Vendor overview
Exhibit 87: Sanofi - Business segments
Exhibit 88: Sanofi - Organizational developments
Exhibit 89: Sanofi - Geographic focus
Exhibit 90: Sanofi - Segment focus
Exhibit 91: Sanofi - Key offerings
Exhibit 92: Sanofi - Key customers
Exhibit 93: Validation techniques employed for market sizing
Exhibit 94: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Allergan Plc
  • Astellas Pharma Inc.
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Sanofi.
  • MORE
The following companies are recognised as the key players in the global pruritus drugs market: Allergan Plc, Astellas Pharma Inc., GlaxoSmithKline Plc, Pfizer Inc., and Sanofi.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the emergence of nanoparticle-enabled transdermal drug delivery systems.”

According to the report, one of the major drivers for this market is the growing preference for immunotherapy.

Further, the report states that one of the major factors hindering the growth of this market is poor patient adherence.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Allergan Plc
  • Astellas Pharma Inc.
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Sanofi.
Note: Product cover images may vary from those shown
Adroll
adroll